Molecular genetics of Alzheimer's disease: The role of β-amyloid and the presenilins

Current Opinion in Neurology

Volumn 13, Issue 4, 2000, Pages 377-384

  Tandon, Anurag ^a   Rogaeva, Ekaterina ^a   Mullan, Michael ^b   St George Hyslop, Peter H ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; FAMILIAL DISEASE; GENE MUTATION; GENETIC LINKAGE; HUMAN; INHERITANCE; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; HUMANS; LINKAGE (GENETICS); MEMBRANE PROTEINS; MOLECULAR BIOLOGY; PRESENILIN-1; PRESENILIN-2;

EID: 0033864011     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200008000-00003     Document Type: Review

References (99)

1. Beta-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
2. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity
3. Purification and cloning of amyloid precursor protein beta-secretase from human brain
4. Identification of a novel aspartic protease (Asp 2) as beta-secretase
5. Human aspartic acid protease memapsin 2 cleaves the
6. Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 - > Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease
7. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
8. Intraneuronal Abeta42 accumulation in human brain
9. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
10. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
11. A familial Alzheimer's disease locus on chromosome 1
12. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo
13. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue
14. Stable association of presenilin derivatives and absence of presenilin interactions with APP
15. Evidence that intramolecular associations between presenilin domains are obligatory for endoproteolytic processing
16. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex
17. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin
18. A detergent-insoluble membrane compartment contains A beta in vivo
19. Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons
20. Interaction of presenilins with the filamin family of actin-binding proteins
21. Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment
22. Presenilins interact with Rab11: A small GTPase involved in the regulation of vesicular transport
23. Evidence for a physical interaction between presenilin and Notch
24. Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/Jif-1
25. Presenilin 1 protein directly interacts with bcl-2
26. Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death
27. Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts
28. Alzheimer's presenilin 1 is a putative membrane receptor for rab GDP dissociation inhibitor
29. Presenilin 1 interaction in the brain with a novel member of the Armadillo family
30. Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin
31. Direct interaction of Alzheimer's disease-related presenilin 1 with armadillo protein p0071
32. Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and beta-amyloid precursor protein
33. Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer disease
34. Lack of interactions between amyloid precursor protein and hydrophilic domains of presenilin 1 and 2 using the yeast two hybrid system
35. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans
36. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing
37. Notch1 is required for the coordinate segmentation of somites
38. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm
39. Skeletal and CNS defects in Presenilin-1-deficient mice
40. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain
41. Presenilin is required for activity and nuclear access of Notch in Drosophila
42. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations
43. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants
44. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
45. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity
46. A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling
47. The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation
48. Photoactivated γ-secretase inhibitors directed to the active site covatently label presenilin 1
49. Presenilin-1 differentially facilitates endoproteolysis of the beta-amyloid precursor protein and Notch
50. Mutation of conserved aspartates affect maturation of both aspartate-mutant and endogenons presenilin 1 and presenilin 2 complexes
51. Presenilin structure: Function and role in Alzheimer's disease
52. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease
53. Amyloid-beta-protein isoforms in brain of subjects with PS1-linked: Beta APP-linked and sporadic Alzheimer disease
54. Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease
55. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant
56. Wide range in age of onset for chromosome 1-related familial Alzheimer's disease
57. Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility iceberg
58. Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risks
59. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans
60. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics
61. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
62. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease
63. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: Independent risk and linkage disequilibrium with the known APOE polymorphism
64. Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE
65. Apolipoprotein E.: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
66. Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease
67. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amytoid precursor protein and mediates its degradation
68. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
69. Neurodegeneration in the central nervous system of apoE-deficient mice
70. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro
71. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization
72. Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia
73. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects
74. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism
75. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease
76. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease
77. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease
78. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease
79. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease
80. N-acetyltransferase (NAT2) genotype and susceptibility of sporadic Alzheimer's disease
81. The human FE65 gene: Genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type
82. Association between Alzheimer's disease and the NOS3 gene
83. No genetic effect of alpha1-antichymotrypsin in Alzheimer disease
84. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease
85. The butyrylcholinasterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations
86. Association between bleomycin hydrolase and Alzheimer's disease in caucasians
87. Presenilin-1 polymorphism and Alzheimer's disease
88. Alpha-2 macroglobulin is genetically associated with Alzheimerx disease
89. An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease
90. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12
91. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity
92. Genetic studies on chromosome 12 in late-onset Alzheimer disease
93. Allelic association but only weak evidence for linkage to the apolipoprotein E locus in late-onset Swedish Alzheimer families
94. Genetic variability at the amyloid-beta precursor protein locus may contribute to the risk of late-onset Alzheimer's disease
95. Genetic linkage analysis of complex genetic traits by using affected sibling pairs
96. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus Potential genetic and phenotypic heterogeneity
97. A full genome scan for late onset Alzheimer's disease
98. A genome survey for novel Alzheimer disease risk loci: Results at 10-cM resolution
99. A familial case of Alzheimer's disease without tau pathology may be linked with chromosome 3 markers